373 related articles for article (PubMed ID: 23436796)
1. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment.
Dijkgraaf EM; Heusinkveld M; Tummers B; Vogelpoel LT; Goedemans R; Jha V; Nortier JW; Welters MJ; Kroep JR; van der Burg SH
Cancer Res; 2013 Apr; 73(8):2480-92. PubMed ID: 23436796
[TBL] [Abstract][Full Text] [Related]
2. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.
Heusinkveld M; de Vos van Steenwijk PJ; Goedemans R; Ramwadhdoebe TH; Gorter A; Welters MJ; van Hall T; van der Burg SH
J Immunol; 2011 Aug; 187(3):1157-65. PubMed ID: 21709158
[TBL] [Abstract][Full Text] [Related]
3. A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
Haegel H; Thioudellet C; Hallet R; Geist M; Menguy T; Le Pogam F; Marchand JB; Toh ML; Duong V; Calcei A; Settelen N; Preville X; Hennequi M; Grellier B; Ancian P; Rissanen J; Clayette P; Guillen C; Rooke R; Bonnefoy JY
MAbs; 2013; 5(5):736-47. PubMed ID: 23924795
[TBL] [Abstract][Full Text] [Related]
4. Tumor associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals.
Jeong SK; Kim JS; Lee CG; Park YS; Kim SD; Yoon SO; Han DH; Lee KY; Jeong MH; Jo WS
Immunobiology; 2017 Jan; 222(1):55-65. PubMed ID: 26705936
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a inhibits human monocyte-derived myeloid dendritic cell generation.
Bergenfelz C; Janols H; Wullt M; Jirström K; Bredberg A; Leandersson K
Scand J Immunol; 2013 Aug; 78(2):194-204. PubMed ID: 23679576
[TBL] [Abstract][Full Text] [Related]
6. IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.
Yousefi H; Momeny M; Ghaffari SH; Parsanejad N; Poursheikhani A; Javadikooshesh S; Zarrinrad G; Esmaeili F; Alishahi Z; Sabourinejad Z; Sankanian G; Shamsaiegahkani S; Bashash D; Shahsavani N; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A
Tumori; 2019 Feb; 105(1):84-91. PubMed ID: 30021477
[TBL] [Abstract][Full Text] [Related]
7. Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.
Mazzoni M; Mauro G; Erreni M; Romeo P; Minna E; Vizioli MG; Belgiovine C; Rizzetti MG; Pagliardini S; Avigni R; Anania MC; Allavena P; Borrello MG; Greco A
J Exp Clin Cancer Res; 2019 May; 38(1):208. PubMed ID: 31113465
[TBL] [Abstract][Full Text] [Related]
8. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.
Chomarat P; Banchereau J; Davoust J; Palucka AK
Nat Immunol; 2000 Dec; 1(6):510-4. PubMed ID: 11101873
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression on tolerogenic APCs is controlled by STAT-3.
Wölfle SJ; Strebovsky J; Bartz H; Sähr A; Arnold C; Kaiser C; Dalpke AH; Heeg K
Eur J Immunol; 2011 Feb; 41(2):413-24. PubMed ID: 21268011
[TBL] [Abstract][Full Text] [Related]
10. Dibenzoylmethane, a Component of Licorice, Suppresses Monocyte-to-Macrophage Differentiation and Inflammatory Responses in Human Monocytes and Mouse Macrophages.
Kang B; Kim JH; Kim CY; Hong J; Choi HS
Biol Pharm Bull; 2018; 41(8):1228-1236. PubMed ID: 30068872
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway.
Fogg KC; Miller AE; Li Y; Flanigan W; Walker A; O'Shea A; Kendziorski C; Kreeger PK
BMC Cancer; 2020 Oct; 20(1):1008. PubMed ID: 33069212
[TBL] [Abstract][Full Text] [Related]
12. Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization.
Mlynska A; Povilaityte E; Zemleckaite I; Zilionyte K; Strioga M; Krasko J; Dobrovolskiene N; Peng MW; Intaite B; Pasukoniene V
Am J Reprod Immunol; 2018 Sep; 80(3):e12996. PubMed ID: 29904979
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells.
Jang YS; Kim TW; Ryu JS; Kong HJ; Jang SH; Nam GH; Kim JH; Jeon S
PLoS One; 2023; 18(2):e0277285. PubMed ID: 36757936
[TBL] [Abstract][Full Text] [Related]
14. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
Dijkgraaf EM; Santegoets SJ; Reyners AK; Goedemans R; Wouters MC; Kenter GG; van Erkel AR; van Poelgeest MI; Nijman HW; van der Hoeven JJ; Welters MJ; van der Burg SH; Kroep JR
Ann Oncol; 2015 Oct; 26(10):2141-9. PubMed ID: 26216383
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors.
Le Naour A; Prat M; Thibault B; Mével R; Lemaitre L; Leray H; Joubert MV; Coulson K; Golzio M; Lefevre L; Mery E; Martinez A; Ferron G; Delord JP; Coste A; Couderc B
J Mol Cell Biol; 2020 Apr; 12(3):202-215. PubMed ID: 31504643
[TBL] [Abstract][Full Text] [Related]
17. Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B.
Chen BC; Liao CC; Hsu MJ; Liao YT; Lin CC; Sheu JR; Lin CH
J Immunol; 2006 Jul; 177(1):681-93. PubMed ID: 16785567
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
19. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
20. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
